Global COVID Vacccine Campaign Asks for $16.8 Billion; Report Says 35% of Already Donated Doses Have Yet To Be Administered 09/02/2022 Paul Adepoju The WHO co-sponsored Act Accelerator Initiative, which aims to get 70% vaccine coverage to all countries by mid-2022, as well as more equal distribution of tests and treatments, tabled its latest ask to donors – for some $16.8 billion in new funds – out of what it says would be a total cost of $48 […] Continue reading -> WHO Africa Region: COVID-19 Vaccination Shifting from Supply-Side to Distribution Challenge 13/01/2022 Paul Adepoju COVID-19 vaccination in Africa may be shifting from a supply challenge – to one of effective vaccine distribution, declared a senior World Health Organization official in the African Region on Thursday. African countries will have adequate access to COVID-19 vaccine supplies in 2022, said Dr Abdou Salam Gueye, Director of Emergency Preparedness and Response, WHO […] Continue reading -> WHO Projection of 3 Billion Dose Vaccine Shortfall In COVID Booster Scenario – ‘Not Based on Valid Data’ Says Pharma 16/12/2021 Elaine Ruth Fletcher A recent WHO estimate that there could be a 3 billion shortfall in COVID vaccine doses needed to vaccinate the world in the first quarter of 2022 – if high-income countries “aggressively” booster adults with third shots as well as immunizing children is not based on “valid, solid” data, charged pharma leader, Thomas Cueni on […] Continue reading -> India’s Covaxin Vaccine Shows 77.8% Efficacy in Interim Phase 3 Results 11/11/2021 Raisa Santos Following World Health Organization approval last week, interim data from a phase 3 trial of BBV152, a COVID-19 vaccine developed in India, reports 77.8% efficacy against symptomatic COVID-19. The study, published in The Lancet, indicated that BBV152 induced a robust antibody response, with the majority of adverse events, including headache, fatigue, fever, and pain at […] Continue reading -> Pakistan, Afghanistan & Yemen Among Countries With Biggest Vaccine Supply Gaps; US Promises More Jabs for Conflict Zones 11/11/2021 Elaine Ruth Fletcher Pakistan and eight other countries, mostly in or around conflict zones, face the largest gaps in vaccine commitments needed to reach a WHO goal of 70% coverage by September 2022. The data is part of a new “COVID Global Tracker” – launched Wednesday during a first-ever meeting of the world’s foreign ministers, convened by US […] Continue reading -> WHO Asks G-20 for $23.4 Billion to Fund COVID Vaccines, Tests & Treatments – and 550 Million Vaccine Doses Immediately! 28/10/2021 Elaine Ruth Fletcher Ahead of a critical G20 meeting this weekend, WHO and its partners are asking the world’s leading industrialized nations to come up with another US$ 23.4 billion over the course of the coming year to address stark shortages in COVID vaccines, tests and treatments remain dismally low in Africa and other parts of the developing […] Continue reading -> Childhood Vaccinations Remain High Despite COVID Pandemic 01/10/2021 Editorial team New statistics from Gavi, the Vaccine Alliance show that routine immunisation programmes have been hit hard by the COVID-19 pandemic. However, the latest data shows that there is extraordinary resilience in immunisation systems, with governments’ efforts to keep childhood vaccinations going despite the impact of the pandemic paying dividends. In the face of the pandemic, […] Continue reading -> Post COVID-19 Summit: WHO Demands ‘Action Now’ on Promised Donations; Civil Society Says Charity Not Enough 24/09/2021 Elaine Ruth Fletcher US President Joe Biden has reaped praise for convening a Global COVID-19 Summit on the margins of this year’s United Nations General Assembly that placed vaccine shortfalls in low- and middle-income countries front and center of GA debates. But it remains to be seen if the big commitments repeated once more this week can break […] Continue reading -> Access Advocates Urge 11th Hour WTO Action on COVID IP Waiver – COVAX Strikes World Bank Deal on Vaccine Finance 26/07/2021 Elaine Ruth Fletcher Vaccine access advocates issued increasingly desperate, last minute calls upon the World Trade Organization to take action over a stalled initiative to impose a temporary waiver on intellectual property for COVID medicines, tests and vaccines – even as the initiative appeared doomed to a stalemate for the rest of the summer. Ahead of the opening […] Continue reading -> Chinese Sinopharm and Sinovac Vaccines to Replenish Global COVAX Facility Supplies 12/07/2021 Editorial team Gavi, the Vaccine Alliance has signed advanced purchase agreements (APAs) with Sinopharm and Sinovac, Chinese biotech firms, to immediately begin supplying the global COVAX Facility with 110 million doses of COVID-19 vaccines, the agency announced on Monday. The agreements come as the Delta variant, first identified in India and classified as a WHO variant of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Africa Region: COVID-19 Vaccination Shifting from Supply-Side to Distribution Challenge 13/01/2022 Paul Adepoju COVID-19 vaccination in Africa may be shifting from a supply challenge – to one of effective vaccine distribution, declared a senior World Health Organization official in the African Region on Thursday. African countries will have adequate access to COVID-19 vaccine supplies in 2022, said Dr Abdou Salam Gueye, Director of Emergency Preparedness and Response, WHO […] Continue reading -> WHO Projection of 3 Billion Dose Vaccine Shortfall In COVID Booster Scenario – ‘Not Based on Valid Data’ Says Pharma 16/12/2021 Elaine Ruth Fletcher A recent WHO estimate that there could be a 3 billion shortfall in COVID vaccine doses needed to vaccinate the world in the first quarter of 2022 – if high-income countries “aggressively” booster adults with third shots as well as immunizing children is not based on “valid, solid” data, charged pharma leader, Thomas Cueni on […] Continue reading -> India’s Covaxin Vaccine Shows 77.8% Efficacy in Interim Phase 3 Results 11/11/2021 Raisa Santos Following World Health Organization approval last week, interim data from a phase 3 trial of BBV152, a COVID-19 vaccine developed in India, reports 77.8% efficacy against symptomatic COVID-19. The study, published in The Lancet, indicated that BBV152 induced a robust antibody response, with the majority of adverse events, including headache, fatigue, fever, and pain at […] Continue reading -> Pakistan, Afghanistan & Yemen Among Countries With Biggest Vaccine Supply Gaps; US Promises More Jabs for Conflict Zones 11/11/2021 Elaine Ruth Fletcher Pakistan and eight other countries, mostly in or around conflict zones, face the largest gaps in vaccine commitments needed to reach a WHO goal of 70% coverage by September 2022. The data is part of a new “COVID Global Tracker” – launched Wednesday during a first-ever meeting of the world’s foreign ministers, convened by US […] Continue reading -> WHO Asks G-20 for $23.4 Billion to Fund COVID Vaccines, Tests & Treatments – and 550 Million Vaccine Doses Immediately! 28/10/2021 Elaine Ruth Fletcher Ahead of a critical G20 meeting this weekend, WHO and its partners are asking the world’s leading industrialized nations to come up with another US$ 23.4 billion over the course of the coming year to address stark shortages in COVID vaccines, tests and treatments remain dismally low in Africa and other parts of the developing […] Continue reading -> Childhood Vaccinations Remain High Despite COVID Pandemic 01/10/2021 Editorial team New statistics from Gavi, the Vaccine Alliance show that routine immunisation programmes have been hit hard by the COVID-19 pandemic. However, the latest data shows that there is extraordinary resilience in immunisation systems, with governments’ efforts to keep childhood vaccinations going despite the impact of the pandemic paying dividends. In the face of the pandemic, […] Continue reading -> Post COVID-19 Summit: WHO Demands ‘Action Now’ on Promised Donations; Civil Society Says Charity Not Enough 24/09/2021 Elaine Ruth Fletcher US President Joe Biden has reaped praise for convening a Global COVID-19 Summit on the margins of this year’s United Nations General Assembly that placed vaccine shortfalls in low- and middle-income countries front and center of GA debates. But it remains to be seen if the big commitments repeated once more this week can break […] Continue reading -> Access Advocates Urge 11th Hour WTO Action on COVID IP Waiver – COVAX Strikes World Bank Deal on Vaccine Finance 26/07/2021 Elaine Ruth Fletcher Vaccine access advocates issued increasingly desperate, last minute calls upon the World Trade Organization to take action over a stalled initiative to impose a temporary waiver on intellectual property for COVID medicines, tests and vaccines – even as the initiative appeared doomed to a stalemate for the rest of the summer. Ahead of the opening […] Continue reading -> Chinese Sinopharm and Sinovac Vaccines to Replenish Global COVAX Facility Supplies 12/07/2021 Editorial team Gavi, the Vaccine Alliance has signed advanced purchase agreements (APAs) with Sinopharm and Sinovac, Chinese biotech firms, to immediately begin supplying the global COVAX Facility with 110 million doses of COVID-19 vaccines, the agency announced on Monday. The agreements come as the Delta variant, first identified in India and classified as a WHO variant of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Projection of 3 Billion Dose Vaccine Shortfall In COVID Booster Scenario – ‘Not Based on Valid Data’ Says Pharma 16/12/2021 Elaine Ruth Fletcher A recent WHO estimate that there could be a 3 billion shortfall in COVID vaccine doses needed to vaccinate the world in the first quarter of 2022 – if high-income countries “aggressively” booster adults with third shots as well as immunizing children is not based on “valid, solid” data, charged pharma leader, Thomas Cueni on […] Continue reading -> India’s Covaxin Vaccine Shows 77.8% Efficacy in Interim Phase 3 Results 11/11/2021 Raisa Santos Following World Health Organization approval last week, interim data from a phase 3 trial of BBV152, a COVID-19 vaccine developed in India, reports 77.8% efficacy against symptomatic COVID-19. The study, published in The Lancet, indicated that BBV152 induced a robust antibody response, with the majority of adverse events, including headache, fatigue, fever, and pain at […] Continue reading -> Pakistan, Afghanistan & Yemen Among Countries With Biggest Vaccine Supply Gaps; US Promises More Jabs for Conflict Zones 11/11/2021 Elaine Ruth Fletcher Pakistan and eight other countries, mostly in or around conflict zones, face the largest gaps in vaccine commitments needed to reach a WHO goal of 70% coverage by September 2022. The data is part of a new “COVID Global Tracker” – launched Wednesday during a first-ever meeting of the world’s foreign ministers, convened by US […] Continue reading -> WHO Asks G-20 for $23.4 Billion to Fund COVID Vaccines, Tests & Treatments – and 550 Million Vaccine Doses Immediately! 28/10/2021 Elaine Ruth Fletcher Ahead of a critical G20 meeting this weekend, WHO and its partners are asking the world’s leading industrialized nations to come up with another US$ 23.4 billion over the course of the coming year to address stark shortages in COVID vaccines, tests and treatments remain dismally low in Africa and other parts of the developing […] Continue reading -> Childhood Vaccinations Remain High Despite COVID Pandemic 01/10/2021 Editorial team New statistics from Gavi, the Vaccine Alliance show that routine immunisation programmes have been hit hard by the COVID-19 pandemic. However, the latest data shows that there is extraordinary resilience in immunisation systems, with governments’ efforts to keep childhood vaccinations going despite the impact of the pandemic paying dividends. In the face of the pandemic, […] Continue reading -> Post COVID-19 Summit: WHO Demands ‘Action Now’ on Promised Donations; Civil Society Says Charity Not Enough 24/09/2021 Elaine Ruth Fletcher US President Joe Biden has reaped praise for convening a Global COVID-19 Summit on the margins of this year’s United Nations General Assembly that placed vaccine shortfalls in low- and middle-income countries front and center of GA debates. But it remains to be seen if the big commitments repeated once more this week can break […] Continue reading -> Access Advocates Urge 11th Hour WTO Action on COVID IP Waiver – COVAX Strikes World Bank Deal on Vaccine Finance 26/07/2021 Elaine Ruth Fletcher Vaccine access advocates issued increasingly desperate, last minute calls upon the World Trade Organization to take action over a stalled initiative to impose a temporary waiver on intellectual property for COVID medicines, tests and vaccines – even as the initiative appeared doomed to a stalemate for the rest of the summer. Ahead of the opening […] Continue reading -> Chinese Sinopharm and Sinovac Vaccines to Replenish Global COVAX Facility Supplies 12/07/2021 Editorial team Gavi, the Vaccine Alliance has signed advanced purchase agreements (APAs) with Sinopharm and Sinovac, Chinese biotech firms, to immediately begin supplying the global COVAX Facility with 110 million doses of COVID-19 vaccines, the agency announced on Monday. The agreements come as the Delta variant, first identified in India and classified as a WHO variant of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
India’s Covaxin Vaccine Shows 77.8% Efficacy in Interim Phase 3 Results 11/11/2021 Raisa Santos Following World Health Organization approval last week, interim data from a phase 3 trial of BBV152, a COVID-19 vaccine developed in India, reports 77.8% efficacy against symptomatic COVID-19. The study, published in The Lancet, indicated that BBV152 induced a robust antibody response, with the majority of adverse events, including headache, fatigue, fever, and pain at […] Continue reading -> Pakistan, Afghanistan & Yemen Among Countries With Biggest Vaccine Supply Gaps; US Promises More Jabs for Conflict Zones 11/11/2021 Elaine Ruth Fletcher Pakistan and eight other countries, mostly in or around conflict zones, face the largest gaps in vaccine commitments needed to reach a WHO goal of 70% coverage by September 2022. The data is part of a new “COVID Global Tracker” – launched Wednesday during a first-ever meeting of the world’s foreign ministers, convened by US […] Continue reading -> WHO Asks G-20 for $23.4 Billion to Fund COVID Vaccines, Tests & Treatments – and 550 Million Vaccine Doses Immediately! 28/10/2021 Elaine Ruth Fletcher Ahead of a critical G20 meeting this weekend, WHO and its partners are asking the world’s leading industrialized nations to come up with another US$ 23.4 billion over the course of the coming year to address stark shortages in COVID vaccines, tests and treatments remain dismally low in Africa and other parts of the developing […] Continue reading -> Childhood Vaccinations Remain High Despite COVID Pandemic 01/10/2021 Editorial team New statistics from Gavi, the Vaccine Alliance show that routine immunisation programmes have been hit hard by the COVID-19 pandemic. However, the latest data shows that there is extraordinary resilience in immunisation systems, with governments’ efforts to keep childhood vaccinations going despite the impact of the pandemic paying dividends. In the face of the pandemic, […] Continue reading -> Post COVID-19 Summit: WHO Demands ‘Action Now’ on Promised Donations; Civil Society Says Charity Not Enough 24/09/2021 Elaine Ruth Fletcher US President Joe Biden has reaped praise for convening a Global COVID-19 Summit on the margins of this year’s United Nations General Assembly that placed vaccine shortfalls in low- and middle-income countries front and center of GA debates. But it remains to be seen if the big commitments repeated once more this week can break […] Continue reading -> Access Advocates Urge 11th Hour WTO Action on COVID IP Waiver – COVAX Strikes World Bank Deal on Vaccine Finance 26/07/2021 Elaine Ruth Fletcher Vaccine access advocates issued increasingly desperate, last minute calls upon the World Trade Organization to take action over a stalled initiative to impose a temporary waiver on intellectual property for COVID medicines, tests and vaccines – even as the initiative appeared doomed to a stalemate for the rest of the summer. Ahead of the opening […] Continue reading -> Chinese Sinopharm and Sinovac Vaccines to Replenish Global COVAX Facility Supplies 12/07/2021 Editorial team Gavi, the Vaccine Alliance has signed advanced purchase agreements (APAs) with Sinopharm and Sinovac, Chinese biotech firms, to immediately begin supplying the global COVAX Facility with 110 million doses of COVID-19 vaccines, the agency announced on Monday. The agreements come as the Delta variant, first identified in India and classified as a WHO variant of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Pakistan, Afghanistan & Yemen Among Countries With Biggest Vaccine Supply Gaps; US Promises More Jabs for Conflict Zones 11/11/2021 Elaine Ruth Fletcher Pakistan and eight other countries, mostly in or around conflict zones, face the largest gaps in vaccine commitments needed to reach a WHO goal of 70% coverage by September 2022. The data is part of a new “COVID Global Tracker” – launched Wednesday during a first-ever meeting of the world’s foreign ministers, convened by US […] Continue reading -> WHO Asks G-20 for $23.4 Billion to Fund COVID Vaccines, Tests & Treatments – and 550 Million Vaccine Doses Immediately! 28/10/2021 Elaine Ruth Fletcher Ahead of a critical G20 meeting this weekend, WHO and its partners are asking the world’s leading industrialized nations to come up with another US$ 23.4 billion over the course of the coming year to address stark shortages in COVID vaccines, tests and treatments remain dismally low in Africa and other parts of the developing […] Continue reading -> Childhood Vaccinations Remain High Despite COVID Pandemic 01/10/2021 Editorial team New statistics from Gavi, the Vaccine Alliance show that routine immunisation programmes have been hit hard by the COVID-19 pandemic. However, the latest data shows that there is extraordinary resilience in immunisation systems, with governments’ efforts to keep childhood vaccinations going despite the impact of the pandemic paying dividends. In the face of the pandemic, […] Continue reading -> Post COVID-19 Summit: WHO Demands ‘Action Now’ on Promised Donations; Civil Society Says Charity Not Enough 24/09/2021 Elaine Ruth Fletcher US President Joe Biden has reaped praise for convening a Global COVID-19 Summit on the margins of this year’s United Nations General Assembly that placed vaccine shortfalls in low- and middle-income countries front and center of GA debates. But it remains to be seen if the big commitments repeated once more this week can break […] Continue reading -> Access Advocates Urge 11th Hour WTO Action on COVID IP Waiver – COVAX Strikes World Bank Deal on Vaccine Finance 26/07/2021 Elaine Ruth Fletcher Vaccine access advocates issued increasingly desperate, last minute calls upon the World Trade Organization to take action over a stalled initiative to impose a temporary waiver on intellectual property for COVID medicines, tests and vaccines – even as the initiative appeared doomed to a stalemate for the rest of the summer. Ahead of the opening […] Continue reading -> Chinese Sinopharm and Sinovac Vaccines to Replenish Global COVAX Facility Supplies 12/07/2021 Editorial team Gavi, the Vaccine Alliance has signed advanced purchase agreements (APAs) with Sinopharm and Sinovac, Chinese biotech firms, to immediately begin supplying the global COVAX Facility with 110 million doses of COVID-19 vaccines, the agency announced on Monday. The agreements come as the Delta variant, first identified in India and classified as a WHO variant of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Asks G-20 for $23.4 Billion to Fund COVID Vaccines, Tests & Treatments – and 550 Million Vaccine Doses Immediately! 28/10/2021 Elaine Ruth Fletcher Ahead of a critical G20 meeting this weekend, WHO and its partners are asking the world’s leading industrialized nations to come up with another US$ 23.4 billion over the course of the coming year to address stark shortages in COVID vaccines, tests and treatments remain dismally low in Africa and other parts of the developing […] Continue reading -> Childhood Vaccinations Remain High Despite COVID Pandemic 01/10/2021 Editorial team New statistics from Gavi, the Vaccine Alliance show that routine immunisation programmes have been hit hard by the COVID-19 pandemic. However, the latest data shows that there is extraordinary resilience in immunisation systems, with governments’ efforts to keep childhood vaccinations going despite the impact of the pandemic paying dividends. In the face of the pandemic, […] Continue reading -> Post COVID-19 Summit: WHO Demands ‘Action Now’ on Promised Donations; Civil Society Says Charity Not Enough 24/09/2021 Elaine Ruth Fletcher US President Joe Biden has reaped praise for convening a Global COVID-19 Summit on the margins of this year’s United Nations General Assembly that placed vaccine shortfalls in low- and middle-income countries front and center of GA debates. But it remains to be seen if the big commitments repeated once more this week can break […] Continue reading -> Access Advocates Urge 11th Hour WTO Action on COVID IP Waiver – COVAX Strikes World Bank Deal on Vaccine Finance 26/07/2021 Elaine Ruth Fletcher Vaccine access advocates issued increasingly desperate, last minute calls upon the World Trade Organization to take action over a stalled initiative to impose a temporary waiver on intellectual property for COVID medicines, tests and vaccines – even as the initiative appeared doomed to a stalemate for the rest of the summer. Ahead of the opening […] Continue reading -> Chinese Sinopharm and Sinovac Vaccines to Replenish Global COVAX Facility Supplies 12/07/2021 Editorial team Gavi, the Vaccine Alliance has signed advanced purchase agreements (APAs) with Sinopharm and Sinovac, Chinese biotech firms, to immediately begin supplying the global COVAX Facility with 110 million doses of COVID-19 vaccines, the agency announced on Monday. The agreements come as the Delta variant, first identified in India and classified as a WHO variant of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Childhood Vaccinations Remain High Despite COVID Pandemic 01/10/2021 Editorial team New statistics from Gavi, the Vaccine Alliance show that routine immunisation programmes have been hit hard by the COVID-19 pandemic. However, the latest data shows that there is extraordinary resilience in immunisation systems, with governments’ efforts to keep childhood vaccinations going despite the impact of the pandemic paying dividends. In the face of the pandemic, […] Continue reading -> Post COVID-19 Summit: WHO Demands ‘Action Now’ on Promised Donations; Civil Society Says Charity Not Enough 24/09/2021 Elaine Ruth Fletcher US President Joe Biden has reaped praise for convening a Global COVID-19 Summit on the margins of this year’s United Nations General Assembly that placed vaccine shortfalls in low- and middle-income countries front and center of GA debates. But it remains to be seen if the big commitments repeated once more this week can break […] Continue reading -> Access Advocates Urge 11th Hour WTO Action on COVID IP Waiver – COVAX Strikes World Bank Deal on Vaccine Finance 26/07/2021 Elaine Ruth Fletcher Vaccine access advocates issued increasingly desperate, last minute calls upon the World Trade Organization to take action over a stalled initiative to impose a temporary waiver on intellectual property for COVID medicines, tests and vaccines – even as the initiative appeared doomed to a stalemate for the rest of the summer. Ahead of the opening […] Continue reading -> Chinese Sinopharm and Sinovac Vaccines to Replenish Global COVAX Facility Supplies 12/07/2021 Editorial team Gavi, the Vaccine Alliance has signed advanced purchase agreements (APAs) with Sinopharm and Sinovac, Chinese biotech firms, to immediately begin supplying the global COVAX Facility with 110 million doses of COVID-19 vaccines, the agency announced on Monday. The agreements come as the Delta variant, first identified in India and classified as a WHO variant of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Post COVID-19 Summit: WHO Demands ‘Action Now’ on Promised Donations; Civil Society Says Charity Not Enough 24/09/2021 Elaine Ruth Fletcher US President Joe Biden has reaped praise for convening a Global COVID-19 Summit on the margins of this year’s United Nations General Assembly that placed vaccine shortfalls in low- and middle-income countries front and center of GA debates. But it remains to be seen if the big commitments repeated once more this week can break […] Continue reading -> Access Advocates Urge 11th Hour WTO Action on COVID IP Waiver – COVAX Strikes World Bank Deal on Vaccine Finance 26/07/2021 Elaine Ruth Fletcher Vaccine access advocates issued increasingly desperate, last minute calls upon the World Trade Organization to take action over a stalled initiative to impose a temporary waiver on intellectual property for COVID medicines, tests and vaccines – even as the initiative appeared doomed to a stalemate for the rest of the summer. Ahead of the opening […] Continue reading -> Chinese Sinopharm and Sinovac Vaccines to Replenish Global COVAX Facility Supplies 12/07/2021 Editorial team Gavi, the Vaccine Alliance has signed advanced purchase agreements (APAs) with Sinopharm and Sinovac, Chinese biotech firms, to immediately begin supplying the global COVAX Facility with 110 million doses of COVID-19 vaccines, the agency announced on Monday. The agreements come as the Delta variant, first identified in India and classified as a WHO variant of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Access Advocates Urge 11th Hour WTO Action on COVID IP Waiver – COVAX Strikes World Bank Deal on Vaccine Finance 26/07/2021 Elaine Ruth Fletcher Vaccine access advocates issued increasingly desperate, last minute calls upon the World Trade Organization to take action over a stalled initiative to impose a temporary waiver on intellectual property for COVID medicines, tests and vaccines – even as the initiative appeared doomed to a stalemate for the rest of the summer. Ahead of the opening […] Continue reading -> Chinese Sinopharm and Sinovac Vaccines to Replenish Global COVAX Facility Supplies 12/07/2021 Editorial team Gavi, the Vaccine Alliance has signed advanced purchase agreements (APAs) with Sinopharm and Sinovac, Chinese biotech firms, to immediately begin supplying the global COVAX Facility with 110 million doses of COVID-19 vaccines, the agency announced on Monday. The agreements come as the Delta variant, first identified in India and classified as a WHO variant of […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Chinese Sinopharm and Sinovac Vaccines to Replenish Global COVAX Facility Supplies 12/07/2021 Editorial team Gavi, the Vaccine Alliance has signed advanced purchase agreements (APAs) with Sinopharm and Sinovac, Chinese biotech firms, to immediately begin supplying the global COVAX Facility with 110 million doses of COVID-19 vaccines, the agency announced on Monday. The agreements come as the Delta variant, first identified in India and classified as a WHO variant of […] Continue reading -> Posts navigation Older postsNewer posts